IMUPRIN

This brand name is authorized in Cyprus, Hong Kong SAR China, Malta.

Active ingredients

The drug IMUPRIN contains one active pharmaceutical ingredient (API):

1	Azathioprine UNII MRK240IY2L - AZATHIOPRINE
	Azathioprine is a pro-drug of 6-mercaptopurine (6-MP). 6-MP is inactive but acts as a purine antagonist and requires cellular uptake and intracellular anabolism to thioguanine nucleotides (TGNs) for immunosuppression. The TGNs and other metabolites (e.g. 6-methyl-mecaptopurine ribonucleotides) inhibit de novo purine synthesis and purine nucleotide interconversions.
	Read more about Azathioprine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
IMUPRIN Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AX01	Azathioprine	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AX Other immunosuppressants
Discover more medicines within L04AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	45098
MT	Medicines Authority	MA084/01101